Woodcock Requests Independent Review Of Biogen-FDA Aduhelm Interaction … Not Approval Decision

 
• By Sarah Karlin-Smith
  
An OIG investigation would put Biogen and FDA’s relationship under a magnifying glass. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership